Lab, Laboratory Supervisor (Schedule: 12:30 pm - 9:00 pm)
Castle Biosciences
Summary
This position supports the clinical laboratory's daily oversight by promoting efficient workflows, providing coaching, and addressing troubleshooting and issue resolution as they arise. The individual serves as a key communication link between laboratory staff and upper management while offering ongoing support to the laboratory team.
Job description
A Day in the Life of a Laboratory Supervisor
This position supports the clinical laboratory's daily oversight by promoting efficient workflows, providing coaching, and addressing troubleshooting and issue resolution as they arise. The individual serves as a key communication link between laboratory staff and upper management while offering ongoing support to the laboratory team.
The supervisor ensures all procedures are performed in accordance with established scientific methodologies and specialized analytical techniques, maintaining full compliance with applicable regulatory standards.
- Supervise day-to-day laboratory operations
- Ensure adherence to quality management system policies and procedures
- Monitor employee productivity
- Provide guidance and coaching to support performance and operational excellence
Schedule
Monday through Friday, 12:30 pm to 9 pm, exempt position, working from the Pittsburgh, PA laboratory. The role may require flexibility to meet operational needs.
Requirements
- Minimum of a bachelor's degree in science related field
- Minimum of 3+ years in a clinical laboratory
- 1 year experience in high complexity molecular testing (CAP)
- Proven experience as Supervisor or similar management role preferred
- Legally authorized to work in the United States
Benefits
- Annual Bonus Potential
- Differential Pay
- 20 PTO Days
- 10 Paid Holidays
- 401(k) 100% Match up to 6%
- 3 Health Care Plan Options
- Company HSA Contribution
- Company Stock Grant
- Company-Paid Garage Parking
Company overview
Castle Biosciences (Nasdaq: CSTL) is a leading molecular diagnostics company that develops and commercializes innovative tests to guide patient care decisions. Founded in 2008 and headquartered in Friendswood, Texas, the company focuses primarily on dermatologic and gastroenterological diseases, with a mission to transform disease management through personalized, clinically actionable solutions. Castle's proprietary portfolio includes five commercial tests targeting unmet clinical needs in dermatologic cancers, Barrett's esophagus, and uveal melanoma. Their flagship product, DecisionDx®-Melanoma, is a gene expression profile test that predicts metastasis risk in cutaneous melanoma patients. The company also markets TissueCypher® for Barrett's esophagus, DecisionDx®-SCC for squamous cell carcinoma, MyPath® Melanoma for lesion characterization, and DecisionDx®-UM for uveal melanoma staging. With laboratory operations in Phoenix, Arizona and Pittsburgh, Pennsylvania, Castle Biosciences employs advanced molecular technologies to provide physicians with objective data for more confident treatment planning. The company reported $83 million in Q3 2025 revenue and has demonstrated strong growth in its core testing franchises, positioning itself as a significant player in the precision diagnostics market.